Keywords: generic, hpv, vacc, cost, under, per, dose
Generic HPV vacc could cost under $15 per dose
Article | 22 October 2007
A generic version of the human papillomavirus (HPV) vaccine is under development by Shantha Biotechnics, a Hyderabad, India-based vaccine producer, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
